MRNA · Moderna
AI read · Neutral
The AI's read
These are personal share sales, and the filing does not say why Hoge is selling. It reports no change to Moderna's business, so it does not point to a change in the company's outlook.
Hoge plans to sell about 39,000 shares after selling about 159,000 since September 14. The filing gives no reason and reports no change to Moderna's business, so it does not change the company's outlook.
These are personal share sales, and the filing does not say why Hoge is selling. It reports no change to Moderna's business, so it does not point to a change in the company's outlook.
Follow Moderna (MRNA) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for MRNA